2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
P LaColla, JP Sommadossi, G Gosselin - US Patent 7,662,798, 2010 - Google Patents
2009-05-06 Assigned to THE CENTRE NATIONAL DEL LA RECHERCHE SCIENTIFICQUE,
UNIVERSITY OF CAGLIARI, L'UNIVERSITE MONTPELLIER II, IDENIX …
UNIVERSITY OF CAGLIARI, L'UNIVERSITE MONTPELLIER II, IDENIX …
2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
P Lacolla, J Sommadossi, G Gosselin - US Patent 7,662,798, 2010 - freepatentsonline.com
2′ and 3′-Prodrugs of 1′, 2′, 3′ or 4′-branched β-D or β-L nucleosides, or their
pharmaceutically acceptable salts and derivatives are described, which are useful in the …
pharmaceutically acceptable salts and derivatives are described, which are useful in the …
2'and 3'-nucleoside prodrugs for treating Flaviviridae infections
P LaColla, JP Sommadossi, G Gosselin… - US Patent App. 10 …, 2007 - Google Patents
2009-05-06 Assigned to IDENIX PHARMACEUTICALS, INC., THE CENTRE NATIONAL DEL
LA RECHERCHE SCIENTIFICQUE, UNIVERSITY OF CAGLIARI, L'UNIVERSITE …
LA RECHERCHE SCIENTIFICQUE, UNIVERSITY OF CAGLIARI, L'UNIVERSITE …
2'and 3'-nucleoside prodrugs for treating Flaviviridae infections
P Lacolla, J Sommadossi… - US Patent App. 10 …, 2007 - freepatentsonline.com
2′ and 3′-Prodrugs of 1′, 2′, 3′ or 4′-branched β-D or β-L nucleosides, or their
pharmaceutically acceptable salts and derivatives are described, which are useful in the …
pharmaceutically acceptable salts and derivatives are described, which are useful in the …